↓ Skip to main content

Edaravone for acute ischaemic stroke

Overview of attention for article published in Cochrane database of systematic reviews, December 2011
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (73rd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
6 tweeters

Citations

dimensions_citation
55 Dimensions

Readers on

mendeley
57 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Edaravone for acute ischaemic stroke
Published in
Cochrane database of systematic reviews, December 2011
DOI 10.1002/14651858.cd007230.pub2
Pubmed ID
Authors

Shejun Feng, Qingwei Yang, Ming Liu, Weizheng Li, Wenming Yuan, Shihong Zhang, Bo Wu, Juntao Li

Abstract

Neuroprotection is a promising therapeutic strategy for the treatment of acute ischaemic stroke. Edaravone is a neuroprotective agent that has been widely used in China, and several studies have suggested that it may be beneficial in acute ischaemic stroke.

Twitter Demographics

The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 57 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 2%
Unknown 56 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 5 9%
Unspecified 4 7%
Student > Ph. D. Student 3 5%
Student > Bachelor 3 5%
Researcher 2 4%
Other 5 9%
Unknown 35 61%
Readers by discipline Count As %
Medicine and Dentistry 11 19%
Agricultural and Biological Sciences 5 9%
Unspecified 4 7%
Neuroscience 1 2%
Computer Science 1 2%
Other 0 0%
Unknown 35 61%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 December 2016.
All research outputs
#3,923,821
of 13,642,069 outputs
Outputs from Cochrane database of systematic reviews
#6,896
of 10,695 outputs
Outputs of similar age
#55,160
of 210,308 outputs
Outputs of similar age from Cochrane database of systematic reviews
#321
of 504 outputs
Altmetric has tracked 13,642,069 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 10,695 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one is in the 35th percentile – i.e., 35% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 210,308 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 504 others from the same source and published within six weeks on either side of this one. This one is in the 36th percentile – i.e., 36% of its contemporaries scored the same or lower than it.